Nonstimulant Therapy for ADHD
Abstract
The results of a multicenter, open-label, dose-titration study of GW320659, a novel norepinephrine and dopamine reuptake inhibitor, are reported from GlaxoSmithKline, Research Triangle Park, NC.
DOI: https://doi.org/10.15844/pedneurbriefs-16-8-11 | Journal eISSN: 2166-6482
Language: English
Page range: 63 - 63
Published on: Aug 1, 2002
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 2002 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.